Jiaqi Shi

6.5k citations
265 papers · 3.8k indexed · h-index 34

Jiaqi Shi

238 papers receiving 3.7k citations

Peers

Jiaqi Shi
Comparison fields: 5 of 174
  • Oncology 1.1k
  • Cancer Research 532
  • Immunology 482
  • Molecular Biology 1.4k
  • Pulmonary and Respiratory Medicine 447
Replace Angelo Carpi with:
Angelo Carpi Italy
Xiaotian Zhang China
Rui Xue China
Huan Zhang China
Elena Bonanno Italy
Lü Chen China
Yifei Li China
Zheng Li China
Wenjie Sun China
Na Huang China
Jiaqi Shi relative to Angelo Carpi Italy Angelo Carpi's profile →
Citations per field
00.5×4.7×
Angelo Carpi · 1×
Citations per year

Countries citing papers authored by Jiaqi Shi

Since Specialization
Citations

This map shows the geographic impact of Jiaqi Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaqi Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaqi Shi more than expected).

Fields of papers citing papers by Jiaqi Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiaqi Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaqi Shi. The network helps show where Jiaqi Shi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jiaqi Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jiaqi Shi Line = papers co-authored together Jiaqi Shi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20253
3 20250
4 20250
5 20244
6 202415
7 20234
8 202315
9 202315
10
Paeoniflorin Sensitizes Breast Cancer Cells to Tamoxifen by Downregulating microRNA-15b via the FOXO1/CCND1/β-Catenin Axis
20210
11
Clinicopathological and Prognostic Significance of EML4-ALK Rearrangement in Patients with Surgically Resected Lung Adenocarcinoma: A Propensity Score Matching Study
20205
12 2019150
13
Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer
20191
14
High expression of dedicator of cytokinesis 1 adversely influences the prognosis of acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation
20191
15
Long noncoding RNA LINC-PINT promotes proliferation through EZH2 and predicts poor prognosis in clear cell renal cell carcinoma
20191
16
Berberine induces apoptosis in non-small-cell lung cancer cells by upregulating miR-19a targeting tissue factor
20194
17
Prediction of biological behavior and prognosis of colorectal cancer patients by tumor MSI/MMR in the Chinese population
20164
18
Manganese dioxide nanosheets-based redox/pH-responsive drug delivery system for cancer theranostic application
20161
19 201371
20 20002

About Jiaqi Shi

Jiaqi Shi is a scholar working on Oncology, Cancer Research and Immunology, having authored 265 papers that have together received 3.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (39 papers), Pancreatitis Pathology and Treatment (13 papers), Cancer Cells and Metastasis (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), Neuroendocrine Tumor Research Advances (10 papers), Epigenetics and DNA Methylation (10 papers), RNA modifications and cancer (8 papers) and Lung Cancer Research Studies (8 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (532 citations) and Immunology (482 citations). Jiaqi Shi has collaborated with scholars based in China, United States and Türkiye. Frequent co-authors include Mark A. Nelson, John W.B. Hershey, Zhen Xu, Ronald R. Watson, Douglas F. Larson, A. K. Bhattacharyya, Marina Pasca di Magliano, Howard C. Crawford, Fushi Wen and Zhangjian Chen. Their work appears in journals such as Advanced Materials, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026